Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery...
Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD (Age-related Macular Degeneration) and...
ALG Health Receives NIOSH Surgical Rating on Three Of Its American Made N95 Respirators
Per the CDC, NIOSH, and National Personal Protective Technology Laboratory Certified Equipment List, ALG Health is one of only three companies who manufacture their...
Cofttek, China’s Largest Manufacturer of PEA, Draws Attention of Investors
Cofttek Holding Limited, a Chinese pharmaceutical manufacturer, has recently drawn the attention of investors, following the U.S. introduction of the FDA drug ultramicronized Palmitoylethanolamide...
Suntrap Discovered ‘LeSoleil’ for COVID-19 and the Epidemic
AI-assisted computing has greatly improved the efficiency of new drug research and development. Suntrap Life Technologies Co., Ltd has taken the lead to establish...
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South...
Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced an exclusive license agreement...
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment
Novamind Inc. (CSE:NM) ("Novamind"), a leading mental health company specialized...
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and...
Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Iterion Therapeutics, Inc., a venture-backed,...
Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for Novel Protein Tyrosine Kinase Inhibitor...
Apollomics licenses worldwide rights (ex-China, Hong Kong and Taiwan) to develop and commercialize EO1001
EO1001 is an irreversible, pan-erbB inhibitor of EGFR (ErbB1),...
[A Share Highlight] Intco Medical (300677:CH) Announced Record High Net Profit with Planned H-share...
Intco Medical (300677:CH), a leading Shenzhen listed personal protective equipment (PPE) provider, announced on 24 January a positive profit alert for the 12 months...
JBM (Healthcare) Limited Debuts on The Main Board of SEHK
JBM (Healthcare) Limited (HKG:2161), a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries, started...
China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race
On February 1, China Medical System (0867.HK) announced that its subsidiary had acquired Luqa Ventures Co., Limited (“Luqa”), a dermatology specialty company. This acquisition expanded its product...
Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia
Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan's Ministry of Health, Labour...
Two Immigrants, One Unique Plan For A Biopharma
This is the story of how the scientific careers of an intrapreneur (Redkar) and an entrepreneur (Yu) came together to cofound and colead...
Olympus launches comprehensive global educational platform for healthcare professionals
Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of a new comprehensive educational platform designed to provide...
Shanghai Longyao Chief Scientist Professor Xuanming Yang published a research article on optimizing CAR-T...
China Biotech Services Holdings Limited (HKG:8037) non-wholly-owned subsidiary Shanghai Longyao Biotechnology Co., Ltd., the Chief Scientist Professor Xuanming Yang published a CD20-CART-OX40 related research...
China Biotech Services LY007 Cell Injection Obtained Clinical Trial Approval Letter
China's first and only CAR-T product with CD20 target approved for registration clinical application
China Biotech Services Holdings Limited ("CH BIOTECH SER" or "Company", stock...
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
- Launch of first pan-Asia Pacific minimum clinical standards for the screening, diagnosis & management of osteoporosis -
The Asia Pacific Consortium on Osteoporosis (APCO)...
Broncus Holding Corporation Closed Series D Financing
Broncus Holding Corporation, a global leader in diagnostic and therapeutic technology for lung diseases, announced today the closing of a Series D round of...
Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities
Olympus Corporation (Olympus - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has entered into an agreement to acquire...
DCH Auriga selected as the logistics partner to distribute the Fosun Pharma BioNTech COVID-19...
DCH Auriga, one of the largest healthcare distributors in Hong Kong with decades of experience managing sophisticated pharmaceutical supply chains, is pleased to announce...